March 04, 2019

Lower Drug Prices Aren't Worth Higher Health Risks

Libby Baney co-authored an article with Thomas E. Menighan, BSPharm, MBA, FAPhA for Drug Topics on the importance of patient safety instead of more affordable medication. 
"While we share the goal of increasing patient access to safe, affordable medicine, the potential cost-saving benefits of importation policies must be sufficiently weighed to account for the considerable risks to patients."Baney and Menighan, drug topics
Full Article
The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.